Run ID: SAMN02414843
Sample name:
Date: 2024-10-05T02:09:30.084324
Number of reads: 20812035
Percentage reads mapped: 98.82
Median coverage: 410.0
Strain: lineage4.8
Spoligotype:
Drug-resistance: MDR-TB
Lineage | Family | RDs | Frequency |
---|---|---|---|
lineage4 | Euro-American | None | 1.0 |
lineage4.8 | Euro-American (mainly T) | RD219 | 1.0 |
Drug | Resistance | Supporting mutations | WHO confidence | Comment |
---|---|---|---|---|
rifampicin | rpoB | p.Ala286Val | Uncertain significance | Mutation from literature |
p.Ser450Leu | Assoc w R | |||
isoniazid | katG | c.-7898_*21866del | Assoc w R | High-level resistance |
ethambutol | ||||
pyrazinamide | pncA | c.-14157_*7700del | Assoc w R | |
streptomycin | gid | c.-306_*28299del | Assoc w R | |
c.-861_*16579del | Assoc w R | |||
fluoroquinolones | ||||
moxifloxacin | ||||
ofloxacin | ||||
levofloxacin | ||||
ciprofloxacin | ||||
aminoglycosides | ||||
amikacin | ||||
capreomycin | tlyA | c.627_*44375del | Assoc w R | |
kanamycin | ||||
cycloserine | ||||
ethionamide | ethA | c.-25870_*21066del | Assoc w R | |
c.-25838_*14482del | Assoc w R | |||
c.-19687_*1475del | Assoc w R | |||
c.-40368_*1333del | Assoc w R | |||
clofazimine | pepQ | c.-12959_*20053del | Assoc w R - Interim | |
c.-4830_*16381del | Assoc w R - Interim | |||
c.-7764_*15122del | Assoc w R - Interim | |||
para-aminosalicylic_acid | thyA | c.-28320_*6105del | Mutation from literature | |
delamanid | fbiD | c.-25630_*5104del | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
c.-18518_*15625del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
fbiA | c.-1873_*38786del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |
ddn | c.-32884_*14581del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |
c.-16708_*10917del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-15577_*15250del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-11453_*4741del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-10403_*33162del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-4678_*32853del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
c.-284_*36132del | Assoc w R - Interim | Confers DLM-PMD cross-resistance | ||
bedaquiline | pepQ | c.-12959_*20053del | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
c.-4830_*16381del | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV | ||
c.-7764_*15122del | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV | ||
linezolid |
Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence | Comment |
---|---|---|---|---|---|---|---|
rpoB | 760663 | p.Ala286Val | missense_variant | 0.99 | rifampicin | Uncertain significance | Mutation from literature |
rpoB | 761155 | p.Ser450Leu | missense_variant | 1.0 | rifampicin | Assoc w R | |
tlyA | 1918565 | c.627_*44375del | frameshift_variant&stop_lost&splice_region_variant | 0.93 | capreomycin | Assoc w R | |
katG | 2132022 | c.-7898_*21866del | transcript_ablation | 0.9 | isoniazid | Assoc w R | High-level resistance |
pncA | 2280980 | c.-14157_*7700del | transcript_ablation | 0.9 | pyrazinamide | Assoc w R | |
pepQ | 2839246 | c.-12959_*20053del | transcript_ablation | 0.94 | bedaquiline | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
clofazimine | Assoc w R - Interim | ||||||
pepQ | 2842918 | c.-4830_*16381del | transcript_ablation | 0.94 | bedaquiline | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
clofazimine | Assoc w R - Interim | ||||||
pepQ | 2844177 | c.-7764_*15122del | transcript_ablation | 0.91 | bedaquiline | Assoc w R - Interim | Includes data from one site that only submitted resistant strains, which may have inflated the PPV |
clofazimine | Assoc w R - Interim | ||||||
thyA | 3067574 | c.-28320_*6105del | transcript_ablation | 0.94 | para-aminosalicylic_acid | Mutation from literature | |
fbiD | 3313487 | c.-25630_*5104del | transcript_ablation | 0.91 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiD | 3320599 | c.-18518_*15625del | transcript_ablation | 0.92 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
fbiA | 3638669 | c.-1873_*38786del | transcript_ablation | 0.91 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3953959 | c.-32884_*14581del | transcript_ablation | 0.93 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3970135 | c.-16708_*10917del | transcript_ablation | 0.97 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3971266 | c.-15577_*15250del | transcript_ablation | 0.91 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3975390 | c.-11453_*4741del | transcript_ablation | 0.92 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3976440 | c.-10403_*33162del | transcript_ablation | 0.91 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3982165 | c.-4678_*32853del | transcript_ablation | 0.93 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ddn | 3986559 | c.-284_*36132del | transcript_ablation | 0.94 | delamanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance |
pretomanid | Assoc w R - Interim | Confers DLM-PMD cross-resistance | |||||
ethA | 4304937 | c.-25870_*21066del | transcript_ablation | 0.93 | ethionamide | Assoc w R | |
ethA | 4311521 | c.-25838_*14482del | transcript_ablation | 0.94 | ethionamide | Assoc w R | |
ethA | 4324528 | c.-19687_*1475del | transcript_ablation | 0.91 | ethionamide | Assoc w R | |
ethA | 4324670 | c.-40368_*1333del | transcript_ablation | 0.92 | ethionamide | Assoc w R | |
gid | 4379228 | c.-306_*28299del | transcript_ablation | 0.94 | streptomycin | Assoc w R | |
gid | 4390948 | c.-861_*16579del | transcript_ablation | 0.93 | streptomycin | Assoc w R |
Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence |
---|---|---|---|---|---|---|
gyrA | 7362 | p.Glu21Gln | missense_variant | 1.0 | levofloxacin | Not assoc w R |
moxifloxacin | Not assoc w R | |||||
Rv0565c | 656265 | c.1204_1205delAC | frameshift_variant | 1.0 | ethionamide | Uncertain significance |
Rv0565c | 656636 | p.Gly279Cys | missense_variant | 1.0 | ethionamide | |
nusG | 734658 | c.405A>G | synonymous_variant | 1.0 | rifampicin | Not assoc w R |
mmpL5 | 775639 | p.Ile948Val | missense_variant | 1.0 | bedaquiline | Not assoc w R - Interim |
clofazimine | Not assoc w R | |||||
rpsL | 781395 | c.-165T>C | upstream_gene_variant | 1.0 | streptomycin | Not assoc w R |
rrs | 1471659 | n.-187C>T | upstream_gene_variant | 1.0 | kanamycin | |
capreomycin | ||||||
streptomycin | ||||||
amikacin | ||||||
rrl | 1474001 | n.344C>T | non_coding_transcript_exon_variant | 1.0 | capreomycin | Not assoc w R |
linezolid | Not assoc w R | |||||
inhA | 1652627 | c.-21574_*8462del | transcript_ablation | 0.92 | isoniazid | |
ethionamide | ||||||
rpsA | 1800105 | c.-33436_*11603del | transcript_ablation | 0.91 | pyrazinamide | Uncertain significance |
tsnR | 1846428 | c.-7177_*34310del | transcript_ablation | 0.93 | linezolid | Uncertain significance |
tlyA | 1917972 | c.33A>G | synonymous_variant | 1.0 | capreomycin | Not assoc w R |
bacA | 2045138 | c.-23360_*17670del | transcript_ablation | 0.94 | kanamycin | Uncertain significance |
capreomycin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
PPE35 | 2168149 | p.Pro822Ser | missense_variant | 0.99 | pyrazinamide | Not assoc w R |
Rv1979c | 2223293 | c.-129A>G | upstream_gene_variant | 1.0 | bedaquiline | Not assoc w R - Interim |
clofazimine | Not assoc w R | |||||
kasA | 2471869 | c.-46245_1073del | exon_loss_variant | 0.92 | isoniazid | |
kasA | 2498225 | c.-19889_*17093del | transcript_ablation | 0.9 | isoniazid | |
eis | 2705775 | c.-22020_*8348del | transcript_ablation | 0.92 | kanamycin | Uncertain significance |
amikacin | Uncertain significance | |||||
eis | 2712823 | c.-26786_*1300del | transcript_ablation | 0.93 | kanamycin | Uncertain significance |
amikacin | Uncertain significance | |||||
ahpC | 2715790 | c.-10402_*2600del | transcript_ablation | 0.91 | isoniazid | Uncertain significance |
Rv2477c | 2774436 | c.-25472_*7929del | transcript_ablation | 0.9 | kanamycin | Uncertain significance |
levofloxacin | Uncertain significance | |||||
moxifloxacin | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
ethambutol | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
Rv2680 | 2960952 | c.-35152_*2431del | transcript_ablation | 0.97 | capreomycin | Uncertain significance |
Rv2680 | 2960973 | c.-35131_*11438del | transcript_ablation | 0.92 | capreomycin | Uncertain significance |
Rv2680 | 2961355 | c.-34749_*14125del | transcript_ablation | 0.93 | capreomycin | Uncertain significance |
Rv2680 | 2987844 | c.-8260_*822del | transcript_ablation | 0.92 | capreomycin | Uncertain significance |
Rv2680 | 2995848 | c.-257G>A | upstream_gene_variant | 0.99 | capreomycin | |
Rv3083 | 3427072 | c.-21431_*24962del | transcript_ablation | 0.95 | ethionamide | Uncertain significance |
Rv3083 | 3428565 | c.-19938_*13117del | transcript_ablation | 0.93 | ethionamide | Uncertain significance |
Rv3083 | 3448497 | c.-7T>A | upstream_gene_variant | 1.0 | ethionamide | |
Rv3083 | 3448507 | c.5_*1408del | frameshift_variant&stop_lost&splice_region_variant | 1.0 | ethionamide | Uncertain significance |
Rv3236c | 3576097 | c.872_*35861del | frameshift_variant&stop_lost&splice_region_variant | 0.92 | pyrazinamide | Uncertain significance |
Rv3236c | 3583506 | c.-2297_*28452del | transcript_ablation | 0.91 | pyrazinamide | Uncertain significance |
Rv3236c | 3586453 | c.745_*25505del | stop_lost&conservative_inframe_deletion&splice_region_variant | 0.92 | pyrazinamide | |
Rv3236c | 3596803 | c.-19308_*15155del | transcript_ablation | 0.9 | pyrazinamide | Uncertain significance |
Rv3236c | 3613636 | c.-520A>G | upstream_gene_variant | 1.0 | pyrazinamide | Not assoc w R |
alr | 3804090 | c.-2985_*36103del | transcript_ablation | 0.93 | cycloserine | |
alr | 3815199 | c.-23219_*24994del | transcript_ablation | 0.96 | cycloserine | |
alr | 3819171 | c.-22390_*21022del | transcript_ablation | 0.95 | cycloserine | |
alr | 3830450 | c.-16796_*9743del | transcript_ablation | 0.93 | cycloserine | |
alr | 3834117 | c.-31992_*6076del | transcript_ablation | 0.93 | cycloserine | |
rpoA | 3852537 | c.-16507_*24926del | transcript_ablation | 0.92 | rifampicin | |
rpoA | 3860251 | c.-22270_*17212del | transcript_ablation | 0.93 | rifampicin | |
rpoA | 3867530 | c.-21139_*9933del | transcript_ablation | 0.91 | rifampicin | |
rpoA | 3870610 | c.-34241_*6853del | transcript_ablation | 0.91 | rifampicin | |
rpoA | 3870800 | c.-25784_*6663del | transcript_ablation | 0.91 | rifampicin | |
rpoA | 3871205 | c.-39355_*6258del | transcript_ablation | 0.92 | rifampicin | |
panD | 4016091 | c.-19913_*27770del | transcript_ablation | 0.95 | pyrazinamide | Uncertain significance |
panD | 4021751 | c.-12898_*22110del | transcript_ablation | 0.91 | pyrazinamide | Uncertain significance |
panD | 4038215 | c.-25039_*5646del | transcript_ablation | 0.93 | pyrazinamide | Uncertain significance |
clpC1 | 4039729 | p.Asp326Asn | missense_variant | 1.0 | pyrazinamide | Not assoc w R |
glpK | 4114198 | c.-6508_*24003del | transcript_ablation | 0.92 | levofloxacin | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
ethambutol | Uncertain significance | |||||
glpK | 4130416 | c.-10897_*7785del | transcript_ablation | 0.94 | levofloxacin | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
ethambutol | Uncertain significance | |||||
glpK | 4135558 | c.-5783_*2643del | transcript_ablation | 0.91 | levofloxacin | Uncertain significance |
moxifloxacin | Uncertain significance | |||||
isoniazid | Uncertain significance | |||||
streptomycin | Uncertain significance | |||||
rifampicin | Uncertain significance | |||||
ethambutol | Uncertain significance | |||||
embA | 4203031 | c.-40201_*1494del | transcript_ablation | 0.93 | ethambutol | Uncertain significance |
embC | 4211482 | c.-28380_2792del | frameshift_variant&start_lost | 0.9 | ethambutol | |
embA | 4218293 | c.-24939_*21214del | transcript_ablation | 0.92 | ethambutol | Uncertain significance |
embA | 4227075 | c.-16157_*27835del | transcript_ablation | 0.9 | ethambutol | Uncertain significance |
embA | 4233247 | c.-9985_*23753del | transcript_ablation | 0.91 | ethambutol | Uncertain significance |
embA | 4238016 | c.-5216_*1009del | transcript_ablation | 0.92 | ethambutol | Uncertain significance |
embC | 4238407 | c.-1455_1053del | start_lost&conservative_inframe_deletion | 0.91 | ethambutol | |
embC | 4239361 | c.-501_*1432del | transcript_ablation | 0.96 | ethambutol | |
embC | 4240549 | c.688_3020del | frameshift_variant | 0.92 | ethambutol | |
embC | 4242643 | c.2781C>T | synonymous_variant | 1.0 | ethambutol | Not assoc w R |
aftB | 4244531 | c.-3143_*22421del | transcript_ablation | 0.91 | ethambutol | Uncertain significance |
embA | 4244847 | c.1616_*1100del | frameshift_variant&stop_lost&splice_region_variant | 0.95 | ethambutol | Uncertain significance |
embB | 4246695 | c.183_*10239del | frameshift_variant&stop_lost&splice_region_variant | 0.95 | ethambutol | |
aftB | 4268508 | c.-41356_328del | frameshift_variant&start_lost | 0.92 | ethambutol | Uncertain significance |
whiB6 | 4331855 | c.-32601_*6315del | transcript_ablation | 0.9 | kanamycin | Uncertain significance |
capreomycin | Uncertain significance | |||||
amikacin | Uncertain significance | |||||
whiB6 | 4338593 | c.-73delT | upstream_gene_variant | 1.0 | kanamycin | |
capreomycin | ||||||
amikacin | ||||||
whiB6 | 4338596 | c.-75G>C | upstream_gene_variant | 1.0 | kanamycin | |
capreomycin | ||||||
amikacin |